NCT06004843View on ClinicalTrials.gov

The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions
HypoxiaHysteroscopyOverweight or Obesity
Interventions
DRUG

remimazolam

in this group,patients are treated with remimazolam and remifentanil for reduced sedation.

DRUG

Propofol

in this group,patients are treated with propofol and remifentanil for reduced sedation.

Trial Locations (1)

Unknown

Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT06004843 - The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients | Biotech Hunter | Biotech Hunter